IBDEI21I ; ; 17-FEB-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,34604,1,3,0)
 ;;=3^Defects in Complement System
 ;;^UTILITY(U,$J,358.3,34604,1,4,0)
 ;;=4^D84.1
 ;;^UTILITY(U,$J,358.3,34604,2)
 ;;=^5002439
 ;;^UTILITY(U,$J,358.3,34605,0)
 ;;=D81.810^^131^1690^5
 ;;^UTILITY(U,$J,358.3,34605,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34605,1,3,0)
 ;;=3^Biotinidase Deficiency
 ;;^UTILITY(U,$J,358.3,34605,1,4,0)
 ;;=4^D81.810
 ;;^UTILITY(U,$J,358.3,34605,2)
 ;;=^5002422
 ;;^UTILITY(U,$J,358.3,34606,0)
 ;;=E88.01^^131^1690^2
 ;;^UTILITY(U,$J,358.3,34606,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34606,1,3,0)
 ;;=3^Apha-1 Antitrypsin Deficiency
 ;;^UTILITY(U,$J,358.3,34606,1,4,0)
 ;;=4^E88.01
 ;;^UTILITY(U,$J,358.3,34606,2)
 ;;=^331442
 ;;^UTILITY(U,$J,358.3,34607,0)
 ;;=J09.X1^^131^1690^25
 ;;^UTILITY(U,$J,358.3,34607,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34607,1,3,0)
 ;;=3^Influenza d/t Indent Novel Influenza A Virus w/ Pneumonia
 ;;^UTILITY(U,$J,358.3,34607,1,4,0)
 ;;=4^J09.X1
 ;;^UTILITY(U,$J,358.3,34607,2)
 ;;=^5008144
 ;;^UTILITY(U,$J,358.3,34608,0)
 ;;=J09.X2^^131^1690^26
 ;;^UTILITY(U,$J,358.3,34608,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34608,1,3,0)
 ;;=3^Influenza d/t Indent Novel Influenza A Virus w/ Resp Manifest
 ;;^UTILITY(U,$J,358.3,34608,1,4,0)
 ;;=4^J09.X2
 ;;^UTILITY(U,$J,358.3,34608,2)
 ;;=^5008145
 ;;^UTILITY(U,$J,358.3,34609,0)
 ;;=J09.X3^^131^1690^27
 ;;^UTILITY(U,$J,358.3,34609,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34609,1,3,0)
 ;;=3^Influenza d/t Indent Novel Influenza A Virus w/ GI Manifest
 ;;^UTILITY(U,$J,358.3,34609,1,4,0)
 ;;=4^J09.X3
 ;;^UTILITY(U,$J,358.3,34609,2)
 ;;=^5008146
 ;;^UTILITY(U,$J,358.3,34610,0)
 ;;=J09.X9^^131^1690^28
 ;;^UTILITY(U,$J,358.3,34610,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34610,1,3,0)
 ;;=3^Influenza d/t Indent Novel Influenza A Virus w/ Oth Manifest
 ;;^UTILITY(U,$J,358.3,34610,1,4,0)
 ;;=4^J09.X9
 ;;^UTILITY(U,$J,358.3,34610,2)
 ;;=^5008147
 ;;^UTILITY(U,$J,358.3,34611,0)
 ;;=J44.9^^131^1690^14
 ;;^UTILITY(U,$J,358.3,34611,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34611,1,3,0)
 ;;=3^COPD,Unspec
 ;;^UTILITY(U,$J,358.3,34611,1,4,0)
 ;;=4^J44.9
 ;;^UTILITY(U,$J,358.3,34611,2)
 ;;=^5008241
 ;;^UTILITY(U,$J,358.3,34612,0)
 ;;=J44.1^^131^1690^12
 ;;^UTILITY(U,$J,358.3,34612,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34612,1,3,0)
 ;;=3^COPD w/ Acute Exacerbation
 ;;^UTILITY(U,$J,358.3,34612,1,4,0)
 ;;=4^J44.1
 ;;^UTILITY(U,$J,358.3,34612,2)
 ;;=^5008240
 ;;^UTILITY(U,$J,358.3,34613,0)
 ;;=J42.^^131^1690^10
 ;;^UTILITY(U,$J,358.3,34613,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34613,1,3,0)
 ;;=3^Bronchitis,Unspec Chronic
 ;;^UTILITY(U,$J,358.3,34613,1,4,0)
 ;;=4^J42.
 ;;^UTILITY(U,$J,358.3,34613,2)
 ;;=^5008234
 ;;^UTILITY(U,$J,358.3,34614,0)
 ;;=J43.9^^131^1690^22
 ;;^UTILITY(U,$J,358.3,34614,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34614,1,3,0)
 ;;=3^Emphysema,Unspec
 ;;^UTILITY(U,$J,358.3,34614,1,4,0)
 ;;=4^J43.9
 ;;^UTILITY(U,$J,358.3,34614,2)
 ;;=^5008238
 ;;^UTILITY(U,$J,358.3,34615,0)
 ;;=J43.0^^131^1690^30
 ;;^UTILITY(U,$J,358.3,34615,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34615,1,3,0)
 ;;=3^MacLeod's Syndrome
 ;;^UTILITY(U,$J,358.3,34615,1,4,0)
 ;;=4^J43.0
 ;;^UTILITY(U,$J,358.3,34615,2)
 ;;=^5008235
 ;;^UTILITY(U,$J,358.3,34616,0)
 ;;=J43.1^^131^1690^21
 ;;^UTILITY(U,$J,358.3,34616,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34616,1,3,0)
 ;;=3^Emphysema,Panlobular
 ;;^UTILITY(U,$J,358.3,34616,1,4,0)
 ;;=4^J43.1
 ;;^UTILITY(U,$J,358.3,34616,2)
 ;;=^5008236
 ;;^UTILITY(U,$J,358.3,34617,0)
 ;;=J43.2^^131^1690^19
 ;;^UTILITY(U,$J,358.3,34617,1,0)
 ;;=^358.31IA^4^2
